JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 47:2513-2520, doi:10.1016/j.jacc.2006.01.070 (Published online 24 May 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Technical Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, P. S.
Right arrow Articles by Oral, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, P. S.
Right arrow Articles by Oral, H.

Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation

Paul S. Chan, MD, MSc*,{dagger},*, Sandeep Vijan, MD, MSc{dagger},{ddagger}, Fred Morady, MD* and Hakan Oral, MD*

* Division of Cardiology, University of Michigan School of Medicine, Ann Arbor, Michigan
{dagger} VA Center for Practice Management and Outcomes Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan
{ddagger} Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan


Figure 1
View larger version (24K):

[in a new window]
 
Figure 1 Simplified diagram of the Markov decision-analytic model. The square at the left represents the three treatment strategy choices. The M represents the Markov process, which leads to one of many health states. The circles represent chance events that may occur in each cycle (e.g., remain well, stroke, hemorrhage, drug toxicity, reversion to atrial fibrillation—not shown) and results in continued good health or one of several disabling states. The branch from Well illustrates these chance events. Health states in the figure are simplified, and each represents multiple states in the actual model (e.g., "disabled" includes separate health states in atrial fibrillation or sinus rhythm with mild or moderate-to-severe disability due to stroke, hemorrhage, left atrial catheter ablation [LACA] complications, or drug toxicity). ICH = intracranial hemorrhage.

 

Figure 2
View larger version (32K):

[in a new window]
 
Figure 2 Main threshold analyses. Varying left atrial catheter ablation (LACA) efficacy rates and annual stroke risks with normal sinus rhythm (NSR) restoration are determined for incremental cost-effectiveness thresholds of $50,000 (diamonds) and $100,000 (squares) per quality-adjusted life-year for 65-year-old (A) and 55-year-old (B) subjects at moderate risk for stroke. For each LACA efficacy rate, LACA would be cost-effective at a specific threshold with stroke risks at or below the threshold lines.

 

Figure 3
View larger version (27K):

[in a new window]
 
Figure 3 Threshold analyses using less conservative model estimates. Threshold analyses were repeated with less conservative estimates for normal sinus rhythm (NSR) restoration with rate control therapy (A), health state utility for atrial fibrillation (B), and annual cost of rate control therapy (C). Analyses shown are for the 65-year-old moderate stroke-risk cohort for a $50,000 per quality-adjusted life-year cost-effectiveness threshold. Diamonds = base-case; squares = less conservative estimate; LACA = left atrial catheter ablation.

 

Figure 4
View larger version (21K):

[in a new window]
 
Figure 4 Tornado diagram of variables with significant influence on incremental cost-effectiveness for the moderate stroke-risk cohorts. Variables identified in one-way sensitivity analysis with the largest impact on incremental cost-effectiveness are depicted. The analysis compares left atrial catheter ablation (LACA) with rate control therapy for 65-year-old (solid bars) and 55-year-old (ruled bars) moderate stroke-risk cohorts. AF = atrial fibrillation; QALY = quality-adjusted life-year.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.